Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 68Neoplasms 32Prostatic Neoplasms 30Lung Neoplasms 24Head and Neck Neoplasms 20Neoplasm Metastasis 15Motor Activity 14Colorectal Neoplasms 14Multiple Myeloma 13Ovarian Neoplasms 11Gastrointestinal Neoplasms 11Fatigue 10Carcinoma, Non-Small-Cell Lung 10cyclopia sequence 8Uterine Cervical Neoplasms 8Pancreatic Neoplasms 8Pain 8Lymphoma 8Anxiety Disorders 8Smoking Cessation 7Recurrence 7Neoplasms, Plasma Cell 7Esophageal Neoplasms 7Endometrial Neoplasms 7Carcinoma, Renal Cell 7Tobacco Use Cessation 6Rectal Neoplasms 6Oropharyngeal Neoplasms 6Leukemia 6Depression 6

Interventions

Dexmedetomidine 5Saline Solution 4Haloperidol 4Sodium Chloride 3Propofol 2Lorazepam 2suvorexant 1remimazolam 1haloperidol decanoate 1flurbiprofen axetil 1dexamethasone 21-phosphate 1Vitamin E 1Surveys and Questionnaires 1Standard of Care 1Sevoflurane 1Practice Guidelines as Topic 1Olanzapine 1Midazolam 1Melatonin 1Interviews as Topic 1Injections 1Inhalation 1Ibuprofen 1Donepezil 1Dexamethasone 1Chlorpromazine 1Anesthesia, Spinal 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Delirium × Surveys and Questionnaires × Clear all
NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
93 enrolled 14 charts
Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡